ArticleMikrochimica acta2025
Creation of an ultra-sensitive and specific molecularly imprinted polymer sensor with ZnO nanoparticle assistance for valganciclovir detection.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Valganciclovir (VGCV) is primarily utilized in the management of cytomegalovirus (CMV) retinitis associated with AIDS and in the prevention of CMV transmission and illness among individuals undergoing organ transplantation. This study aimed to create nanomaterial-enhanced porous interfaces through a molecular imprinting strategy to facilitate the selective detection of VGCV. The sensor was fabricated via a photopolymerization technique on a glassy carbon electrode (GCE), employing VGCV as the template and 2-acrylamido-2-methyl-1-propane sulfonic acid (AMPS) as the functional monomer. The incorporation of zinc oxide nanoparticles (ZnO NPs) substantially enhanced the active surface area and porosity of the sensor. Comprehensive electrochemical and morphological assessments of the VGCV/AMPS/ZnO NPs/MIP-GCE sensor were performed utilizing scanning electron microscopy, cyclic voltammetry, and electrochemical impedance spectroscopy. The sensor demonstrated the capability to detect VGCV within a concentration ranging from 1 to 20 pM through an indirect measurement method. The calculated limits of detection for standard and serum samples were 2.89 × 10− 13 M and 1.99 × 10− 13 M, respectively, underscoring the sensor’s sensitivity and practicality. The imprinting factor (IF) investigation was conducted on a few medications that are structurally comparable to VGCV, revealing relative IF values that confirmed the sensor’s selectivity for VGCV. To further comprehend the interactions between the template and functional monomer, density functional theory computations were used. These theoretical analyses not only supported the adjustment of the template and monomer ratio experimentally but also revealed how these interactions change in the presence of ZnO NPs, allowing for the evaluation of their impact on binding energies.
Indexed as
Identifiers
41410693What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.